Skip to content
Trial Eligibility
Menu

Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV

NCT06554717

This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .

Summary

People with HIV experience earlier impairments in physical function compared to people in the general population. They also exhibit an earlier presentation and more rapid development of frailty, a multisystemic syndrome of aging characterized by reduced activity, fatigue, slowness, weakness, and weight loss. While exercise can improve physical function in people with HIV, it is less effective in doing so than in the general population and is difficult to sustain in the long-term.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • HIV-1-infection
  • Frailty
  • Impaired Physical Function
  • Abdominal Obesity
  • Aging

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
50 to 80 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
May 19, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Colorado · 1

  • University of Colorado - Anschutz Medical Campus · Aurora, CO

Massachusetts · 1

  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.